
Structure Therapeutics Inc. – NASDAQ:GPCR
Structure Therapeutics stock price today
Structure Therapeutics stock price monthly change
Structure Therapeutics stock price quarterly change
Structure Therapeutics stock price yearly change
Structure Therapeutics key metrics
Market Cap | 1.59B |
Enterprise value | N/A |
P/E | N/A |
EV/Sales | N/A |
EV/EBITDA | N/A |
Price/Sales | N/A |
Price/Book | N/A |
PEG ratio | N/A |
EPS | -2.32 |
Revenue | N/A |
EBITDA | -114.99M |
Income | -97.84M |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
Profit margin | 0% |
Oper. margin | 0% |
Gross margin | 0% |
EBIT margin | 0% |
EBITDA margin | N/A |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeStructure Therapeutics stock price history
Structure Therapeutics stock forecast
Structure Therapeutics financial statements
Jun 2023 | 0 | -23.28M | |
---|---|---|---|
Sep 2023 | 0 | -23.86M | |
Dec 2023 | 1.32M | -24.67M | -1855.04% |
Mar 2024 | 0 | -26.03M |
Mar 2024 | 0 | -26.03M | |
---|---|---|---|
Sep 2025 | 0 | -13.45M | |
Oct 2025 | 0 | -13.97M | |
Dec 2025 | 0 | -15.21M |
Analysts Price target
Financials & Ratios estimates
2023-11-14 | -0.29 | -0.62 |
---|---|---|
2024-03-08 | -0.21 | -0.17 |
2024-05-09 | -0.21 | -0.19 |
Jun 2023 | 229428000 | 15.01M | 6.54% |
---|---|---|---|
Sep 2023 | 216370000 | 23.40M | 10.82% |
Dec 2023 | 482017096 | 29.05M | 6.03% |
Mar 2024 | 457220419 | 27.40M | 5.99% |
Jun 2023 | -16.89M | -68.71M | -297K |
---|---|---|---|
Sep 2023 | -20.55M | 30.12M | 473K |
Dec 2023 | -21.90M | -180.88M | 281.97M |
Mar 2024 | -34.02M | 1.41M | 700.85K |
Structure Therapeutics alternative data
Aug 2023 | 68 |
---|---|
Sep 2023 | 77 |
Oct 2023 | 77 |
Nov 2023 | 77 |
Dec 2023 | 87 |
Jan 2024 | 87 |
Feb 2024 | 87 |
Mar 2024 | 93 |
Apr 2024 | 93 |
May 2024 | 93 |
Jun 2024 | 93 |
Jul 2024 | 111 |
Structure Therapeutics other data
Period | Buy | Sel |
---|---|---|
Oct 2023 | 0 | 17454 |
Dec 2023 | 0 | 17454 |
Feb 2024 | 0 | 525 |
Mar 2024 | 0 | 21997 |
Jun 2024 | 0 | 220400 |
Viking Therapeutics: Competition Fears Are Exaggerated
Pfizer: Headwinds Dissipating, New Obesity Pipeline Update Coming Soon
Structure Therapeutics: Tipping The Scales In Obesity Management
U.S. IPO Weekly Recap: July Closes Out With 2023's First Direct Listing And A Wave Of Small IPOs
Structure Therapeutics: Developing Innovative Treatments For Metabolic And Fibrotic Diseases
-
What's the price of Structure Therapeutics stock today?
One share of Structure Therapeutics stock can currently be purchased for approximately $18.92.
-
When is Structure Therapeutics's next earnings date?
Unfortunately, Structure Therapeutics's (GPCR) next earnings date is currently unknown.
-
Does Structure Therapeutics pay dividends?
No, Structure Therapeutics does not pay dividends.
-
How much money does Structure Therapeutics make?
Structure Therapeutics has a market capitalization of 1.59B. Structure Therapeutics made a loss 89.62M US dollars in net income (profit) last year or -$0.19 on an earnings per share basis.
-
What is Structure Therapeutics's stock symbol?
Structure Therapeutics Inc. is traded on the NASDAQ under the ticker symbol "GPCR".
-
What is Structure Therapeutics's primary industry?
Company operates in the Healthcare sector and Biotechnology industry.
-
How do i buy shares of Structure Therapeutics?
Shares of Structure Therapeutics can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
How many employees does Structure Therapeutics have?
As Jul 2024, Structure Therapeutics employs 111 workers, which is 19% more then previous month and 19% more then previous quarter.
-
When Structure Therapeutics went public?
Structure Therapeutics Inc. is publicly traded company for more then 2 years since IPO on 3 Feb 2023.
-
What is Structure Therapeutics's official website?
The official website for Structure Therapeutics is structuretx.com.
-
Where are Structure Therapeutics's headquarters?
Structure Therapeutics is headquartered at 611 Gateway Boulevard, South San Francisco, CA.
-
How can i contact Structure Therapeutics?
Structure Therapeutics's mailing address is 611 Gateway Boulevard, South San Francisco, CA and company can be reached via phone at +62 82299277.
Structure Therapeutics company profile:

Structure Therapeutics Inc.
structuretx.comNASDAQ
136
Biotechnology
Healthcare
Structure Therapeutics Inc., a clinical stage global biopharmaceutical company, develops and delivers novel oral therapeutics to treat a range of chronic diseases with unmet medical needs. Its lead product candidate is GSBR-1290, an oral and biased small molecule agonist of glucagon-like-peptide-1 receptor, a validated G-protein-coupled receptors (GPCRs) drug target for type-2 diabetes mellitus and obesity. The company is also developing oral small molecule therapeutics targeting other GPCRs for the treatment of pulmonary and cardiovascular diseases, including ANPA-0073, a biased agonist, targeting apelin receptor, a GPCR that has been implicated in idiopathic pulmonary fibrosis (IPF) and pulmonary arterial hypertension; and LTSE-2578, an investigational oral small molecule lysophosphatidic acid 1 receptor antagonist for the treatment of IPF. The company was formerly known as ShouTi Inc. Structure Therapeutics Inc. was founded in 2016 and is headquartered in South San Francisco, California.
South San Francisco, CA 94080
CIK: 0001888886
ISIN: US86366E1064
CUSIP: 86366E106